Transform drug discovery and development with our groundbreaking AI platform for biological simulation. Create digital twins from cells to complete human systems for faster, safer, and more cost-effective therapeutic innovation.
Built specifically for complex biological simulation with multi-scale modeling capabilities and deep learning algorithms trained on vast biomedical datasets.
Seamlessly connect cellular, tissue, organ, and whole-human models for comprehensive therapeutic testing and biological insight.
Leverage unlimited computational resources for real-time modeling that scales with your research needs, accessible from anywhere.
Our platform creates digital replicas of cellular mechanisms that respond to stimuli exactly like their biological counterparts, enabling precise intervention testing.
Proprietary algorithms connect molecular, cellular, and systems biology for unprecedented accuracy in predicting biological responses across scales.
Digital twins continuously update from experimental data, creating an ever-improving simulation environment that grows more accurate with each use.
Design and modify cell-based therapies in a risk-free virtual environment before moving to costly production and testing phases.
Accurately predict how the immune system will respond to CAR-T, mRNA, and gene therapies across diverse patient profiles.
Identify potential cytokine release syndrome and other adverse effects before clinical testing begins, saving time and reducing risk.
Fine-tune therapeutic dosing using thousands of virtual trials to determine optimal effectiveness with minimal side effects.
Tailored simulations based on individual genomic profiles
Interconnected organ models for comprehensive drug response
Accurate prediction of physiological outcomes from genetic data
Virtual patient cohorts for trial design optimization
Our whole-human simulations connect genetic information to physiological outcomes, enabling precision medicine approaches and significantly reducing the need for traditional clinical testing phases.
Reduction in preclinical development timelines for partner companies
Genome-to-phenome accuracy in published validation studies
Global pharmaceutical giants currently using our platform
Average reduction in early-phase testing expenses
Our platform has demonstrated significant ROI across therapeutic areas including oncology, immunology, and rare diseases, with multiple partners progressing to accelerated regulatory approval.
Cloud-based APIs enable seamless integration with existing R&D workflows and computational systems. Begin generating valuable insights within days, not months.
GxP-compliant environment with comprehensive documentation to support regulatory submissions. All simulations include validation reports suitable for inclusion in FDA/EMA filings.
Choose from monthly subscriptions for specific projects, annual enterprise licenses for organization-wide access, or custom partnership arrangements for strategic collaborations.
Dedicated team of PhD scientists ensures optimal platform usage and provides regular model updates incorporating the latest scientific advances and validation data.
Schedule a personalized demonstration with our scientific team tailored to your specific therapeutic areas and research goals.
Our experts will assess your current pipeline and identify specific applications where our platform can deliver maximum impact.
Develop a customized roadmap for incorporating our digital twin technology into your R&D workflow and computational infrastructure.
Begin transforming your drug discovery and development process with cutting-edge AI simulation technology.
Revolutionizing Life Sciences: The AI Platform for Digital Twins & In Silico Simulation